207 related articles for article (PubMed ID: 16435157)
1. Ghrelin alleviates cancer chemotherapy-associated dyspepsia in rodents.
Liu YL; Malik NM; Sanger GJ; Andrews PL
Cancer Chemother Pharmacol; 2006 Sep; 58(3):326-33. PubMed ID: 16435157
[TBL] [Abstract][Full Text] [Related]
2. Adaptive upregulation of gastric and hypothalamic ghrelin receptors and increased plasma ghrelin in a model of cancer chemotherapy-induced dyspepsia.
Malik NM; Moore GB; Kaur R; Liu YL; Wood SL; Morrow RW; Sanger GJ; Andrews PL
Regul Pept; 2008 Jun; 148(1-3):33-8. PubMed ID: 18455814
[TBL] [Abstract][Full Text] [Related]
3. Intracisternal des-acyl ghrelin inhibits food intake and non-nutrient gastric emptying in conscious rats.
Chen CY; Chao Y; Chang FY; Chien EJ; Lee SD; Doong ML
Int J Mol Med; 2005 Oct; 16(4):695-9. PubMed ID: 16142407
[TBL] [Abstract][Full Text] [Related]
4. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism.
Takeda H; Sadakane C; Hattori T; Katsurada T; Ohkawara T; Nagai K; Asaka M
Gastroenterology; 2008 Jun; 134(7):2004-13. PubMed ID: 18439428
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of dexamethasone, ondansetron and a tachykinin NK1 receptor antagonist (GR205171) on cisplatin-induced changes in behaviour, food intake, pica and gastric function in rats.
Malik NM; Liu YL; Cole N; Sanger GJ; Andrews PL
Eur J Pharmacol; 2007 Jan; 555(2-3):164-73. PubMed ID: 17141213
[TBL] [Abstract][Full Text] [Related]
6. Enhanced gastrointestinal motility with orally active ghrelin receptor agonists.
Charoenthongtrakul S; Giuliana D; Longo KA; Govek EK; Nolan A; Gagne S; Morgan K; Hixon J; Flynn N; Murphy BJ; Hernández AS; Li J; Tino JA; Gordon DA; DiStefano PS; Geddes BJ
J Pharmacol Exp Ther; 2009 Jun; 329(3):1178-86. PubMed ID: 19252061
[TBL] [Abstract][Full Text] [Related]
7. Ghrelin attenuates the inhibitory effects of glucagon-like peptide-1 and peptide YY(3-36) on food intake and gastric emptying in rats.
Chelikani PK; Haver AC; Reidelberger RD
Diabetes; 2006 Nov; 55(11):3038-46. PubMed ID: 17065340
[TBL] [Abstract][Full Text] [Related]
8. Behavioural and hypothalamic molecular effects of the anti-cancer agent cisplatin in the rat: A model of chemotherapy-related malaise?
Malik NM; Moore GB; Smith G; Liu YL; Sanger GJ; Andrews PL
Pharmacol Biochem Behav; 2006 Jan; 83(1):9-20. PubMed ID: 16443263
[TBL] [Abstract][Full Text] [Related]
9. Altered feeding behaviour induced by long-term cisplatin in rats.
Vera G; Chiarlone A; Martín MI; Abalo R
Auton Neurosci; 2006 Jun; 126-127():81-92. PubMed ID: 16567130
[TBL] [Abstract][Full Text] [Related]
10. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis.
Tack J; Depoortere I; Bisschops R; Verbeke K; Janssens J; Peeters T
Aliment Pharmacol Ther; 2005 Nov; 22(9):847-53. PubMed ID: 16225494
[TBL] [Abstract][Full Text] [Related]
11. The orexigenic effect of peripheral ghrelin differs between rats of different age and with different baseline food intake, and it may in part be mediated by the area postrema.
Gilg S; Lutz TA
Physiol Behav; 2006 Feb; 87(2):353-9. PubMed ID: 16356516
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin-induced gastrointestinal dysmotility is aggravated after chronic administration in the rat. Comparison with pica.
Cabezos PA; Vera G; Martín-Fontelles MI; Fernández-Pujol R; Abalo R
Neurogastroenterol Motil; 2010 Jul; 22(7):797-805, e224-5. PubMed ID: 20236245
[TBL] [Abstract][Full Text] [Related]
13. Pica--a model of nausea? Species differences in response to cisplatin.
Liu YL; Malik N; Sanger GJ; Friedman MI; Andrews PL
Physiol Behav; 2005 Jun; 85(3):271-7. PubMed ID: 15939445
[TBL] [Abstract][Full Text] [Related]
14. Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin.
Rudd JA; Ngan MP; Wai MK; King AG; Witherington J; Andrews PL; Sanger GJ
Neurosci Lett; 2006 Jan; 392(1-2):79-83. PubMed ID: 16182445
[TBL] [Abstract][Full Text] [Related]
15. Lack of ghrelin secretion in response to fasting in cholecystokinin-A (-1), -B (-2) receptor-deficient mice.
Sakurai C; Ohta M; Kanai S; Uematsu H; Funakoshi A; Miyasaka K
J Physiol Sci; 2006 Dec; 56(6):441-7. PubMed ID: 17134539
[TBL] [Abstract][Full Text] [Related]
16. D-methionine improves cisplatin-induced anorexia and dyspepsia syndrome by attenuating intestinal tryptophan hydroxylase 1 activity and increasing plasma leptin concentration.
Wong YS; Lin MY; Liu PF; Ko JL; Huang GT; Tu DG; Ou CC
Neurogastroenterol Motil; 2020 Jun; 32(6):e13803. PubMed ID: 31989744
[TBL] [Abstract][Full Text] [Related]
17. Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures.
Mack CM; Moore CX; Jodka CM; Bhavsar S; Wilson JK; Hoyt JA; Roan JL; Vu C; Laugero KD; Parkes DG; Young AA
Int J Obes (Lond); 2006 Sep; 30(9):1332-40. PubMed ID: 16534527
[TBL] [Abstract][Full Text] [Related]
18. Preproghrelin-derived peptide, obestatin, fails to influence food intake in lean or obese rodents.
Gourcerol G; Coskun T; Craft LS; Mayer JP; Heiman ML; Wang L; Million M; St-Pierre DH; Taché Y
Obesity (Silver Spring); 2007 Nov; 15(11):2643-52. PubMed ID: 18070755
[TBL] [Abstract][Full Text] [Related]
19. Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin.
Asakawa A; Inui A; Fujimiya M; Sakamaki R; Shinfuku N; Ueta Y; Meguid MM; Kasuga M
Gut; 2005 Jan; 54(1):18-24. PubMed ID: 15591499
[TBL] [Abstract][Full Text] [Related]
20. Administration of ghrelin to young uraemic rats increases food intake transiently, stimulates growth hormone secretion and does not improve longitudinal growth.
Alvarez-García O; García-López E; Rodríguez J; Gil-Peña H; Molinos I; Carbajo-Pérez E; Santos F
Nephrol Dial Transplant; 2007 May; 22(5):1309-13. PubMed ID: 17317714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
